NCT01632033
Completed
Not Applicable
Estimation de la capacité Fonctionnelle a la Marche Par Questionnaire Clinique Chez Des Patients adressés Pour Bilan artériel Des Membres inférieurs: Etude WELCH-bis
University Hospital, Angers1 site in 1 country150 target enrollmentJuly 2012
ConditionsPeripheral Artery Disease
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Peripheral Artery Disease
- Sponsor
- University Hospital, Angers
- Enrollment
- 150
- Locations
- 1
- Primary Endpoint
- Scoring of the WELCH. Percent scored questionnaires
- Status
- Completed
- Last Updated
- 10 years ago
Overview
Brief Summary
The purpose of this study is to test the routine faisibility of a questionnaire to estimate walking impairment(The WELCH questionnaire) in patients investigated for suspected PAD.
Detailed Description
The WELCH and WIQ questionnaires are self completed by the patients and scored by the physician after self-completion.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Sigjned consent for the data treatment as a database
Exclusion Criteria
- •Non french native language age \< 18 years old
Outcomes
Primary Outcomes
Scoring of the WELCH. Percent scored questionnaires
Time Frame: 1 day
Predetermined scored . Scoring is optional and compared to scoring of the WIQ
Study Sites (1)
Loading locations...
Similar Trials
Unknown
Phase 4
Walking Estimated Limitation Calculated by History - Study 2Peripheral Artery DiseaseNCT01424020University Hospital, Angers800
Terminated
Not Applicable
Walking Impairment Questionnaire in PADPeripheral Artery DiseaseNCT01114178University Hospital, Angers340
Completed
Not Applicable
Feasibility of Home-based Measurement of Walking Capacity Using Global Positioning System in Peripheral Artery DiseasePeripheral Artery DiseaseNCT01141361University Hospital, Angers251
Recruiting
Not Applicable
Assessing Functional Capacity in Directly and Remotely Monitored Home-based Settings: A Protocol for a Multinational Validation Study in Individuals With Chronic Respiratory DiseasesCOPD Chronic Obstructive Pulmonary DiseaseInterstitial Lung DiseaseNCT06447831Laval University82
Completed
Phase 4
A Prospective, Open-label, Non-randomized, Clinical Trial to Determine if Natalizumab (Tysabri®) Improves Ambulatory Measures in Relapsing-remitting Multiple Sclerosis (RRMS) PatientsRelapsing Remitting Multiple Sclerosis (RRMS)NCT00871780Biogen224